Previous close | 268.53 |
Open | N/A |
Bid | 381.00 |
Ask | 390.00 |
Strike | 510.00 |
Expiry date | 2024-11-15 |
Day's range | 268.53 - 268.53 |
Contract range | N/A |
Volume | |
Open interest | 10 |
Nvidia’s fight to remain the world’s most valuable company begins, disappointing retail sales raise hopes for a September rate cut, and more news to start your day.
On Jun 10, the FDA's Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) voted 11-0, unanimously recommending the approval of Eli Lilly's (LLY) Alzheimer's disease drug, donanemab.
Moody's released a new report Tuesday that reins in Wall Street expectations for the impact of GLP-1s on other industries.